Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial-Reference-Cited by-同舟云学术

Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial

Published:2016-04 Issue:10026 Volume:387 Page:1405-1414
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Zalcman Gérard,Mazieres Julien,Margery Jacques,Greillier Laurent,Audigier-Valette Clarisse,Moro-Sibilot Denis,Molinier Olivier,Corre Romain,Monnet Isabelle,Gounant Valérie,Rivière Frédéric,Janicot Henri,Gervais Radj,Locher Chrystèle,Milleron Bernard,Tran Quan,Lebitasy Marie-Paule,Morin Franck,Creveuil Christian,Parienti Jean-Jacques,Scherpereel Arnaud

Publisher

Elsevier BV

Subject

General Medicine

Reference34 articles.

1. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province;Wagner;Br J Ind Med,1960

2. Prognostic factors for mesothelioma;Steele;Hematol Oncol Clin North Am,2005

3. What is the survival after surgery for localized malignant pleural mesothelioma?;Gelvez-Zapata;Interact Cardiovasc Thorac Surg,2013

4. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma;Vogelzang;J Clin Oncol,2003

5. Phase II study of pemetrexed plus carboplatin in malignant pleural mesothelioma;Ceresoli;J Clin Oncol,2006

Cited by 748 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive clinical overview of malignant pleural mesothelioma;Respiratory Medicine;2024-02

2. Diffuse Pleural Mesothelioma: Advances in Molecular Pathogenesis, Diagnosis, and Treatment;Annual Review of Pathology: Mechanisms of Disease;2024-01-24

3. Peritoneal mesothelioma and pseudomyxoma peritonei;best practice onkologie;2024-01-22

4. Adipo-oncology: adipocyte-derived factors govern engraftment, survival, and progression of metastatic cancers;Cell Communication and Signaling;2024-01-18

5. Immunotherapy of mesothelioma: the evolving change of a long-standing therapeutic dream;Frontiers in Immunology;2024-01-08